Ruth M. de Tute

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Meral Beksaç, Ludmila Bezdîčková et al. · Haematologica · 2008 · 514 citations · Full text

Medicine, Hematology, Pathology +17

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Andy C. Rawstron, J. A. Child, Ruth M. de Tute et al. · Journal of Clinical Oncology · 2013 · 419 citations

Medicine, Hematology, Oncology +17

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis et al. · Leukemia · 2015 · 241 citations · Full text

Medicine, Hematology, Oncology +17

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

Andy C. Rawstron, Sebastian Böttcher, Rémi Letestu et al. · Leukemia · 2012 · 205 citations

Medicine, Hematology, Oncology +15

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction

Andy C. Rawstron, Walter M. Gregory, Ruth M. de Tute et al. · Blood · 2015 · 182 citations

Medicine, Hematology, Oncology +16